IQVIA Careers logo

IQVIA Careers

Global healthcare data, analytics and clinical research company serving life sciences, with a 22,000 plus person delivery base in India

iqvia.com

About the company

Legal name

IQVIA Holdings Inc.

CFO

Mike Fedock, Executive Vice President and Chief Financial Officer

Founded

1982 as Quintiles; IQVIA formed in 2016 from the Quintiles and IMS Health merger and renamed in 2017

Employees

About 93,000 globally, 22,000+ in India

Industry

Healthcare data and analytics, clinical research (CRO), health information technology

Revenue (FY25)

$16.31 billion, up 5.87% year on year

Market Cap

About $33.13 billion (July 2026)

Listed on

NYSE: IQV, an S&P 500 component

IQVIA Holdings Inc. is an American healthcare data, analytics and clinical research company listed on the NYSE under the ticker IQV. It was formed in 2016 when Quintiles, the contract research organization incorporated in North Carolina in 1982, merged with the healthcare data provider IMS Health. The combined business took the IQVIA name in 2017, where the I stands for IMS Health, the Q for Quintiles and VIA for by way of. The company is headquartered in Durham, North Carolina.

The business sells analytics, technology platforms and clinical research services to pharmaceutical, biotech, medtech and consumer health customers, and reports through two segments: Commercial Solutions and R&D Solutions. Work spans Phase I to Phase IV clinical trials, laboratory services, real world evidence, pharmacovigilance and regulatory compliance, plus commercial data products sold through its Connected Intelligence platform. FY2025 revenue was $16.31 billion, and first quarter 2026 revenue was $4,151 million, up 8.4% year on year, with full year 2026 guidance reaffirmed at $17.15 billion to $17.35 billion. Roughly 93,000 people work for IQVIA across more than 100 countries.

India is one of IQVIA's largest delivery bases, with more than 22,000 employees across cities including Bengaluru, Mumbai, Thane, Gurugram, Delhi, Noida, Pune, Hyderabad, Chennai, Kolkata and Ahmedabad. The main India operating entity for clinical work is IQVIA RDS (India) Private Limited, registered in Bangalore, which reported FY2025 revenue of about Rs 3,342 crore. India teams cover clinical data management, database design, safety and pharmacovigilance, statistical programming, technology engineering and consulting.

Key People

Ari Bousbib

Chairman and Chief Executive Officer

Mike Fedock

Executive Vice President, Chief Financial Officer

Trudy Stein

Executive Vice President, Chief Human Resources Officer

Alistair Grenfell

President, Commercial Solutions

Photos

IQVIA workplace 1

Interview process at IQVIA

(Based on 259 interview reports from IQVIA candidates in India)

Interview experience

Favourable, 7 out of 10

Interview difficulty

Medium, 6 out of 10

Interview process length

About a week to two weeks for most candidates

Overall experience

PoorExcellent
EasyDifficult

How long the process takes

About a day or two10%
About a week52%
About a month18%
More than one month20%

See all IQVIA interview questions & answers

Browse question banks by role, round and company, with answers and examples.

IQVIA Salaries in India (Updated 2026)

Consultant

Average across submissions

₹15,07,157/year

24 salaries Salaries submitted

Senior Consultant

Average across submissions

₹21,83,090/year

7 salaries Salaries submitted

Associate Consultant

Average across submissions

₹10,22,210/year

12 salaries Salaries submitted

Software Engineer

Average across submissions

₹9,51,985/year

29 salaries Salaries submitted

Senior Software Engineer

Average across submissions

₹15,93,897/year

13 salaries Salaries submitted

Programmer

Average across submissions

₹9,72,036/year

7 salaries Salaries submitted

Know your worth at IQVIA

Benchmark your pay against live market data before you negotiate.

Get ready for an AI interview

Free guides to AI video screens, coding tests and how scoring works.

Benefits

Health insurance
Dental insurance
Vision insurance
Life insurance and AD&D cover
Disability insurance
Employee Assistance Program with confidential counselling
401(k) with 50% match on the first 4% of base salary (US plan)
Annual bonus, averaging ₹1,17,000 in India
Paid time off covering vacation and personal days
Around 12 vacation days a year reported by India employees
Paid sick time
Maternity and paternity leave
Volunteer time off
Free Udemy learning access reported by India employees
Learning and development programmes
Tuition reimbursement
Remote work options

Latest News & Updates

May 13, 2026

IQVIA and Kexing Biopharm expand biosimilar collaboration

IQVIA expanded its strategic collaboration with Kexing Biopharm to support a global, multi product biosimilar development and commercialization program using AI enabled clinical capabilities. The work covers clinical development, regulatory strategy, analytics and commercialization for international markets.

#Partnership #Biosimilars #AI

View post

May 5, 2026

IQVIA reports first quarter 2026 results

Revenue reached $4,151 million, up 8.4% reported and 6.0% at constant currency, with Commercial Solutions at $1,754 million and R&D Solutions at $2,397 million. The company reaffirmed full year revenue guidance of $17.15 billion to $17.35 billion and raised adjusted diluted EPS guidance to $12.65 to $12.95.

#Earnings #Financials

View post

February 25, 2026

IQVIA to acquire drug discovery assets from Charles River Laboratories

IQVIA signed an agreement to buy five in vitro drug discovery sites from Charles River Laboratories, including lab based New Approach Methodologies and a small molecule AI platform. The deal was expected to close in the second quarter of 2026.

#Acquisition #DrugDiscovery

View post

January 29, 2026

Boehringer Ingelheim picks IQVIA DaaS+ for global commercial data transformation

Boehringer Ingelheim selected IQVIA's Data as a Service platform to harmonize commercial data reporting across 59 countries. The long term collaboration supports brand and franchise reporting plus upcoming product launches.

#Partnership #Data

View post

September 2, 2025

IQVIA announces CFO transition for early 2026

Michael Fedock, then SVP of Financial Planning and Analysis, was named Executive Vice President and Chief Financial Officer effective February 28, 2026. He succeeded Ron Bruehlman, who retired as CFO and stayed on as senior advisor to CEO Ari Bousbib.

#Leadership #CFO

View post

IQVIA FAQ

IQVIA sells healthcare data, analytics, technology platforms and clinical research services to pharmaceutical, biotech, medtech and consumer health customers. It reports through two segments, Commercial Solutions and R&D Solutions, covering Phase I to Phase IV trials, lab services, real world evidence, pharmacovigilance and commercial data products.

Last updated: